Novel Drugs of Abuse: Cannabinoids, Stimulants, and Hallucinogens

Evan S. Herrmann; Patrick S. Johnson; Matthew W. Johnson; Ryan Vandrey

doi:10.1016/B978-0-12-800634-4.00088-3

Novel Drugs of Abuse: Cannabinoids, Stimulants, and Hallucinogens

Evan S. Herrmann, Patrick S. Johnson, Matthew W. Johnson, Ryan Vandrey

School of Medicine

Research output: Chapter in Book/Report/Conference proceeding › Chapter

2 Scopus citations

Abstract

A paradigm shift in the illicit drug market has occurred in the 21st century with a dramatic increase in the number of novel psychoactive drugs available. These novel drugs of abuse include: synthetic cannabinoids; synthetic cathinones; novel phenethylamines, piperazines, and tryptamines; and Salvia divinorum. This chapter provides an overview of these compounds, with emphasis on providing basic information on the history, pharmacology, epidemiology, and behavioral effects. Similarities and differences of substances in each category with regard to molecular structure and physiological, subjective, and behavioral effects are highlighted. We also present safety concerns associated with use of these drugs, and describe how attempts to regulate the legal status of novel drugs may promote an ever-growing number and variety of psychoactive drugs available for nonmedical use.

Original language	English (US)
Title of host publication	Neuropathology of Drug Addictions and Substance Misuse Volume 3
Subtitle of host publication	General Processes and Mechanisms, Prescription Medications, Caffeine and Areca, Polydrug Misuse, Emerging Addictions and Non-Drug Addictions
Publisher	Elsevier
Pages	893-902
Number of pages	10
Volume	3
ISBN (Electronic)	9780128006771
ISBN (Print)	9780128006344
DOIs	https://doi.org/10.1016/B978-0-12-800634-4.00088-3
State	Published - Jan 1 2016

Keywords

Phenethylamines
Piperazines
Salvia divinorum
Synthetic cannabinoids
Synthetic cathinones
Tryptamines

ASJC Scopus subject areas

General Medicine
General Neuroscience

Access to Document

10.1016/B978-0-12-800634-4.00088-3

Cite this

Herrmann, E. S., Johnson, P. S., Johnson, M. W., & Vandrey, R. (2016). Novel Drugs of Abuse: Cannabinoids, Stimulants, and Hallucinogens. In Neuropathology of Drug Addictions and Substance Misuse Volume 3: General Processes and Mechanisms, Prescription Medications, Caffeine and Areca, Polydrug Misuse, Emerging Addictions and Non-Drug Addictions (Vol. 3, pp. 893-902). Elsevier. https://doi.org/10.1016/B978-0-12-800634-4.00088-3

Novel Drugs of Abuse: Cannabinoids, Stimulants, and Hallucinogens. / Herrmann, Evan S.; Johnson, Patrick S.; Johnson, Matthew W. et al.
Neuropathology of Drug Addictions and Substance Misuse Volume 3: General Processes and Mechanisms, Prescription Medications, Caffeine and Areca, Polydrug Misuse, Emerging Addictions and Non-Drug Addictions. Vol. 3 Elsevier, 2016. p. 893-902.

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Herrmann, ES, Johnson, PS, Johnson, MW & Vandrey, R 2016, Novel Drugs of Abuse: Cannabinoids, Stimulants, and Hallucinogens. in Neuropathology of Drug Addictions and Substance Misuse Volume 3: General Processes and Mechanisms, Prescription Medications, Caffeine and Areca, Polydrug Misuse, Emerging Addictions and Non-Drug Addictions. vol. 3, Elsevier, pp. 893-902. https://doi.org/10.1016/B978-0-12-800634-4.00088-3

Herrmann ES, Johnson PS, Johnson MW, Vandrey R. Novel Drugs of Abuse: Cannabinoids, Stimulants, and Hallucinogens. In Neuropathology of Drug Addictions and Substance Misuse Volume 3: General Processes and Mechanisms, Prescription Medications, Caffeine and Areca, Polydrug Misuse, Emerging Addictions and Non-Drug Addictions. Vol. 3. Elsevier. 2016. p. 893-902 doi: 10.1016/B978-0-12-800634-4.00088-3

Herrmann, Evan S. ; Johnson, Patrick S. ; Johnson, Matthew W. et al. / Novel Drugs of Abuse : Cannabinoids, Stimulants, and Hallucinogens. Neuropathology of Drug Addictions and Substance Misuse Volume 3: General Processes and Mechanisms, Prescription Medications, Caffeine and Areca, Polydrug Misuse, Emerging Addictions and Non-Drug Addictions. Vol. 3 Elsevier, 2016. pp. 893-902

@inbook{9ba1455c83e849d2904e1af7f0f78105,

title = "Novel Drugs of Abuse: Cannabinoids, Stimulants, and Hallucinogens",

abstract = "A paradigm shift in the illicit drug market has occurred in the 21st century with a dramatic increase in the number of novel psychoactive drugs available. These novel drugs of abuse include: synthetic cannabinoids; synthetic cathinones; novel phenethylamines, piperazines, and tryptamines; and Salvia divinorum. This chapter provides an overview of these compounds, with emphasis on providing basic information on the history, pharmacology, epidemiology, and behavioral effects. Similarities and differences of substances in each category with regard to molecular structure and physiological, subjective, and behavioral effects are highlighted. We also present safety concerns associated with use of these drugs, and describe how attempts to regulate the legal status of novel drugs may promote an ever-growing number and variety of psychoactive drugs available for nonmedical use.",

keywords = "Phenethylamines, Piperazines, Salvia divinorum, Synthetic cannabinoids, Synthetic cathinones, Tryptamines",

author = "Herrmann, {Evan S.} and Johnson, {Patrick S.} and Johnson, {Matthew W.} and Ryan Vandrey",

year = "2016",

month = jan,

day = "1",

doi = "10.1016/B978-0-12-800634-4.00088-3",

language = "English (US)",

isbn = "9780128006344",

volume = "3",

pages = "893--902",

booktitle = "Neuropathology of Drug Addictions and Substance Misuse Volume 3",

publisher = "Elsevier",

}

TY - CHAP

T1 - Novel Drugs of Abuse

T2 - Cannabinoids, Stimulants, and Hallucinogens

AU - Herrmann, Evan S.

AU - Johnson, Patrick S.

AU - Johnson, Matthew W.

AU - Vandrey, Ryan

PY - 2016/1/1

Y1 - 2016/1/1

N2 - A paradigm shift in the illicit drug market has occurred in the 21st century with a dramatic increase in the number of novel psychoactive drugs available. These novel drugs of abuse include: synthetic cannabinoids; synthetic cathinones; novel phenethylamines, piperazines, and tryptamines; and Salvia divinorum. This chapter provides an overview of these compounds, with emphasis on providing basic information on the history, pharmacology, epidemiology, and behavioral effects. Similarities and differences of substances in each category with regard to molecular structure and physiological, subjective, and behavioral effects are highlighted. We also present safety concerns associated with use of these drugs, and describe how attempts to regulate the legal status of novel drugs may promote an ever-growing number and variety of psychoactive drugs available for nonmedical use.

AB - A paradigm shift in the illicit drug market has occurred in the 21st century with a dramatic increase in the number of novel psychoactive drugs available. These novel drugs of abuse include: synthetic cannabinoids; synthetic cathinones; novel phenethylamines, piperazines, and tryptamines; and Salvia divinorum. This chapter provides an overview of these compounds, with emphasis on providing basic information on the history, pharmacology, epidemiology, and behavioral effects. Similarities and differences of substances in each category with regard to molecular structure and physiological, subjective, and behavioral effects are highlighted. We also present safety concerns associated with use of these drugs, and describe how attempts to regulate the legal status of novel drugs may promote an ever-growing number and variety of psychoactive drugs available for nonmedical use.

KW - Phenethylamines

KW - Piperazines

KW - Salvia divinorum

KW - Synthetic cannabinoids

KW - Synthetic cathinones

KW - Tryptamines

UR - http://www.scopus.com/inward/record.url?scp=84978355588&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978355588&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-800634-4.00088-3

DO - 10.1016/B978-0-12-800634-4.00088-3

M3 - Chapter

AN - SCOPUS:84978355588

SN - 9780128006344

VL - 3

SP - 893

EP - 902

BT - Neuropathology of Drug Addictions and Substance Misuse Volume 3

PB - Elsevier

ER -

Novel Drugs of Abuse: Cannabinoids, Stimulants, and Hallucinogens

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this